Reviva Reports Second Quarter 2023 Financial Results and Recent Business Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Wall St futures tick higher after tech rout; Mideast, tariffs in focus
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil retreats from above $100, but set for weekly rise on Middle East escalation
- Meta’s new seller app hits eBay where it hurts most
- American Express down 2% in premarket trade after Q2 revenue miss offsets EPS beat
Reviva Pharmaceuticals Holdings, Inc. (RVPH) Misses Q2 EPS by 27c
August 14, 2023 4:22 PM EDTReviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q2 EPS of ($0.55), $0.27 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.
... More